Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology - Ireland
doi 10.1016/j.mce.2009.10.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Prevalence and Prognostic Value of BRAFV600E Mutation in Papillary Thyroid Cancer

International Journal of Human and Health Sciences (IJHHS)
2019English

Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2020English

The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer

Journal of Cancer
Oncology
2020English

BRAFV600E Mutation and Papillary Thyroid Cancer—In Reply

JAMA - Journal of the American Medical Association
Medicine
2013English

Surgical Tactics Optimization for Treatment of BRAF Positive Papillary Thyroid Cancer

Clinical and experimental thyroidology
2018English

Prognostic Importance of Immunologochemical Markers of Papillary Thyroid Cancer

ScienceRise: Medical Science
2019English

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

PLoS ONE
Multidisciplinary
2014English

Reduced Expression of THRβ in Papillary Thyroid Carcinomas: Relationship With BRAF Mutation, Aggressiveness and miR Expression

Journal of Endocrinological Investigation
EndocrinologyMetabolismDiabetes
2015English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy